Drug Shortage Report for ENGERIX-B

Last updated on 2020-03-25 History
Report ID 105174
Drug Identification Number 02487039
Brand name ENGERIX-B
Common or Proper name Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 20MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's (prefilled syringe / seringue préremplie)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-02-03
Estimated end date 2020-03-27
Actual end date 2020-03-24
Shortage status Resolved
Updated date 2020-03-25
Company comments Inventory on allocation to support demand in private market. Supply available for public programs.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-03-25 French Compare
v6 2020-03-25 English Compare
v5 2020-03-20 French Compare
v4 2020-03-20 English Compare
v3 2020-02-04 English Compare
v2 2020-02-03 French Compare
v1 2020-02-03 English Compare